86 related articles for article (PubMed ID: 2828407)
1. Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions.
Bliziotes M; Yergey AL; Nanes MS; Muenzer J; Begley MG; Vieira NE; Kher KK; Brandi ML; Marx SJ
J Clin Endocrinol Metab; 1988 Feb; 66(2):294-300. PubMed ID: 2828407
[TBL] [Abstract][Full Text] [Related]
2. Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy.
Sakati N; Woodhouse NJ; Niles N; Harfi H; de Grange DA; Marx S
Horm Res; 1986; 24(4):280-7. PubMed ID: 3023230
[TBL] [Abstract][Full Text] [Related]
3. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
Balsan S; Garabedian M; Liberman UA; Eil C; Bourdeau A; Guillozo H; Grimberg R; Le Deunff MJ; Lieberherr M; Guimbaud P; Broyer M; Marx SJ
J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
[TBL] [Abstract][Full Text] [Related]
4. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII).
al-Aqeel A; Ozand P; Sobki S; Sewairi W; Marx S
Clin Endocrinol (Oxf); 1993 Aug; 39(2):229-37. PubMed ID: 8396512
[TBL] [Abstract][Full Text] [Related]
5. A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
Yagi H; Ozono K; Miyake H; Nagashima K; Kuroume T; Pike JW
J Clin Endocrinol Metab; 1993 Feb; 76(2):509-12. PubMed ID: 8381803
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D.
Balsan S; Garabédian M; Larchet M; Gorski AM; Cournot G; Tau C; Bourdeau A; Silve C; Ricour C
J Clin Invest; 1986 May; 77(5):1661-7. PubMed ID: 3009551
[TBL] [Abstract][Full Text] [Related]
8. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues.
Weisman Y; Jaccard N; Legum C; Spirer Z; Yedwab G; Even L; Edelstein S; Kaye AM; Hochberg Z
J Clin Endocrinol Metab; 1990 Oct; 71(4):937-43. PubMed ID: 2169482
[TBL] [Abstract][Full Text] [Related]
10. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L
J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D.
Marx SJ; Bliziotes MM; Nanes M
Clin Endocrinol (Oxf); 1986 Oct; 25(4):373-81. PubMed ID: 3040300
[TBL] [Abstract][Full Text] [Related]
12. Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D.
Weisman Y; Bab I; Gazit D; Spirer Z; Jaffe M; Hochberg Z
Am J Med; 1987 Nov; 83(5):984-90. PubMed ID: 2823606
[TBL] [Abstract][Full Text] [Related]
13. Hereditary resistance to 1,25-dihydroxyvitamin D: defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone.
Liberman UA; Eil C; Holst P; Rosen JF; Marx SJ
J Clin Endocrinol Metab; 1983 Nov; 57(5):958-62. PubMed ID: 6311866
[TBL] [Abstract][Full Text] [Related]
14. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
[TBL] [Abstract][Full Text] [Related]
15. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D.
Marx SJ; Spiegel AM; Brown EM; Gardner DG; Downs RW; Attie M; Hamstra AJ; DeLuca HF
J Clin Endocrinol Metab; 1978 Dec; 47(6):1303-10. PubMed ID: 233695
[TBL] [Abstract][Full Text] [Related]
16. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
17. Increased intestinal absorption of calcium in young and adult X-linked hypophosphatemic mice after the administration of 1,25-dihydroxyvitamin D3.
Meyer MH; Meyer RA
J Bone Miner Res; 1988 Apr; 3(2):151-7. PubMed ID: 3213610
[TBL] [Abstract][Full Text] [Related]
18. Evidence for involvement of 17beta-estradiol in intestinal calcium absorption independent of 1,25-dihydroxyvitamin D3 level in the Rat.
Colin EM; Van Den Bemd GJ; Van Aken M; Christakos S; De Jonge HR; Deluca HF; Prahl JM; Birkenhäger JC; Buurman CJ; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1999 Jan; 14(1):57-64. PubMed ID: 9893066
[TBL] [Abstract][Full Text] [Related]
19. Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action.
Pattanaungkul S; Riggs BL; Yergey AL; Vieira NE; O'Fallon WM; Khosla S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4023-7. PubMed ID: 11095427
[TBL] [Abstract][Full Text] [Related]
20. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II.
Malloy PJ; Hochberg Z; Pike JW; Feldman D
J Clin Endocrinol Metab; 1989 Feb; 68(2):263-9. PubMed ID: 2537329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
